| 1 |
Devarajan N, Nathan J, Mathangi R, Mahendra J, Ganesan SK. Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management. J Biochem Mol Toxicol 2023;37:e23278. [PMID: 36588295 DOI: 10.1002/jbt.23278] [Reference Citation Analysis]
|
| 2 |
Jin Y, Zhang J, Pan Y, Shen W. Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway. Integr Cancer Ther 2022;21:15347354221130303. [PMID: 36255058 DOI: 10.1177/15347354221130303] [Reference Citation Analysis]
|
| 3 |
Kang Y, Wang J, Lee J, Lee N, Son C. Coptidis Rhizoma Suppresses Metastatic Behavior by Inhibiting TGF-β-Mediated Epithelial-Mesenchymal Transition in 5-FU-Resistant HCT116 Cells. Front Pharmacol 2022;13:909331. [DOI: 10.3389/fphar.2022.909331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Kashyap A, Umar SM, Dev A, Mendiratta M, Prasad CP. In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Zhu Y, Xie N, Chai Y, Nie Y, Liu K, Liu Y, Yang Y, Su J, Zhang C. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Front Pharmacol 2022;13:803717. [PMID: 35153781 DOI: 10.3389/fphar.2022.803717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 6 |
Du H, Gu J, Peng Q, Wang X, Liu L, Shu X, He Q, Tan Y. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF-β/Smad Pathway. Oxid Med Cell Longev 2021;2021:2337818. [PMID: 34712379 DOI: 10.1155/2021/2337818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Li G, Zhang C, Liang W, Zhang Y, Shen Y, Tian X. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells. Pharm Biol 2021;59:21-30. [PMID: 33417512 DOI: 10.1080/13880209.2020.1865407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 8 |
Wang Z, Wang L, Shi B, Sun X, Xie Y, Yang H, Zi C, Wang X, Sheng J. Demethyleneberberine promotes apoptosis and suppresses TGF-β/Smads induced EMT in the colon cancer cells HCT-116. Cell Biochem Funct 2021;39:763-70. [PMID: 34028068 DOI: 10.1002/cbf.3638] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 9 |
Li P, Hao Z, Liu H, Zhu B, Dang L, Ma C, Xu Y, Zhang Y, Fan D, Sun S. Quantitative Proteomics Analysis of Berberine-Treated Colon Cancer Cells Reveals Potential Therapy Targets. Biology (Basel) 2021;10:250. [PMID: 33806918 DOI: 10.3390/biology10030250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, Wang R, Wang T, Qiu Y, Yu H. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother 2021;133:111044. [PMID: 33378952 DOI: 10.1016/j.biopha.2020.111044] [Cited by in Crossref: 53] [Cited by in F6Publishing: 63] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 11 |
Bu HQ, Shen F, Cui J. The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo. Onco Targets Ther 2019;12:7467-76. [PMID: 31686852 DOI: 10.2147/OTT.S220401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
